These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2167536

  • 1. Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients.
    Rondeau E, Farquet C, Ruedin P, Fries D, Sraer JD.
    Transplant Proc; 1990 Aug; 22(4):1813-4. PubMed ID: 2167536
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of renal transplant-associated cytomegalovirus infection with ganciclovir.
    Nicholson ML, Veitch PS, Donnelly PK, Flower AJ, Bell PR.
    Transplant Proc; 1990 Aug; 22(4):1811-2. PubMed ID: 2167535
    [No Abstract] [Full Text] [Related]

  • 3. Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients.
    Buturović-Ponikvar J, Kandus A, Malovrh M, Ponikvar R, Kveder R.
    Transplant Proc; 1992 Oct; 24(5):1921-3. PubMed ID: 1329287
    [No Abstract] [Full Text] [Related]

  • 4. The CARI guidelines. CMV disease and kidney transplant: treatment of cytomegalovirus disease in renal transplant recipients.
    Caring for Australians with Renal Impairment (CARI).
    Nephrology (Carlton); 2004 Oct; 9 Suppl 3():S37-40. PubMed ID: 15469554
    [No Abstract] [Full Text] [Related]

  • 5. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E, Ozaki KS, Tomiyama H, Granato CF, Camara NO, Pacheco-Silva A.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2031-7. PubMed ID: 17161359
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 20; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 7. Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients.
    Murray BM, Subramaniam S.
    Transpl Infect Dis; 2004 Mar 20; 6(1):3-9. PubMed ID: 15225220
    [Abstract] [Full Text] [Related]

  • 8. Treatment of transplant rejection in the presence of cytomegalovirus viremia.
    O'Hair DP, Johnson CP, Roza AM, Adams MB.
    Transplant Proc; 1990 Aug 20; 22(4):1815-7. PubMed ID: 2167537
    [No Abstract] [Full Text] [Related]

  • 9. Cytomegalovirus infection in renal transplantation.
    Barton EN, Rigg KM, Morgan AG, Burden RP.
    West Indian Med J; 1995 Jun 20; 44(2):74-6. PubMed ID: 7667977
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus infection in pediatric kidney transplantation.
    Fontana I, Verrina E, Timitilli A, Arcuri V, Basile G, Losurdo G, Rabagliati AM, Perfumo F, Giacchino R, Gusmano R.
    Transplant Proc; 1994 Feb 20; 26(1):18-9. PubMed ID: 8108929
    [No Abstract] [Full Text] [Related]

  • 11. Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence.
    Hakkert A, Dykeman-Sharpe J.
    CANNT J; 2003 Feb 20; 13(3):69-73; quiz 74-5. PubMed ID: 14596201
    [No Abstract] [Full Text] [Related]

  • 12. Viral escape and T-cell immunity during ganciclovir treatment of cytomegalovirus infection: case report of a pancreatico-renal transplant recipient.
    Benz C, Holz G, Michel D, Awerkiew S, Dries V, Stippel D, Goeser T, Busch DH.
    Transplantation; 2003 Mar 15; 75(5):724-7. PubMed ID: 12640316
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus infection in renal transplant recipients.
    Carstens J, Andersen HK, Spencer E, Madsen M.
    Transpl Infect Dis; 2006 Dec 15; 8(4):203-12. PubMed ID: 17116133
    [Abstract] [Full Text] [Related]

  • 14. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec 15; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 15. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
    Pavlopoulou ID, Syriopoulou VP, Chelioti H, Daikos GL, Stamatiades D, Kostakis A, Boletis JN.
    Clin Microbiol Infect; 2005 Sep 15; 11(9):736-43. PubMed ID: 16104989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients.
    Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y.
    J Antimicrob Chemother; 2005 Mar 15; 55(3):391-4. PubMed ID: 15705636
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.